GAFFX
Price
$86.88
Change
+$0.68 (+0.79%)
Updated
Sep 8 closing price
Net Assets
332.38B
WLGRX
Price
$35.49
Change
+$0.17 (+0.48%)
Updated
Sep 8 closing price
Net Assets
7.99B
Interact to see
Advertisement

GAFFX vs WLGRX

Header iconGAFFX vs WLGRX Comparison
Open Charts GAFFX vs WLGRXBanner chart's image
American Funds Growth Fund of Amer F3
Price$86.88
Change+$0.68 (+0.79%)
VolumeN/A
Net Assets332.38B
Macquarie Large Cap Growth Fund R
Price$35.49
Change+$0.17 (+0.48%)
VolumeN/A
Net Assets7.99B
GAFFX vs WLGRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GAFFX vs. WLGRX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and WLGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 332B vs. WLGRX (7.99B). GAFFX pays higher dividends than WLGRX: GAFFX (0.59) vs WLGRX (0.00). GAFFX was incepted earlier than WLGRX: GAFFX (9 years) vs WLGRX (20 years). WLGRX (1.24) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. WLGRX (18.00). WLGRX has a lower initial minimum investment than GAFFX: WLGRX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 22.13 vs. WLGRX (11.53). GAFFX return over 5 years is better than : 46.66 vs. WLGRX (29.05).
GAFFXWLGRXGAFFX / WLGRX
Total Expense Ratio0.301.1426%
Annual Report Gross Expense Ratio0.301.2424%
Fund Existence9 years20 years-
Gain YTD16.6646.098273%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets332B7.99B4,154%
Annual Yield % from dividends0.590.00-
Returns for 1 year22.1311.53192%
Returns for 3 years54.2844.28123%
Returns for 5 years46.6629.05161%
Returns for 10 yearsN/A92.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMAC7.161.02
+16.61%
DiaMedica Therapeutics
CTSO0.980.02
+1.74%
Cytosorbents Corp
HALO75.850.92
+1.23%
Halozyme Therapeutics
CHARU10.82N/A
N/A
Charlton Aria Acquisition Corp
TXG13.93-0.03
-0.21%
10x Genomics